RBC Capital Assumes Clarivate Plc (CLVT) at Outperform

Go back to RBC Capital Assumes Clarivate Plc (CLVT) at Outperform

Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences

August 4, 2021 4:00 AM UTC

Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customers to make more informed decisions

LONDON, Aug. 4, 2021 /PRNewswire/ -- Clarivate Plc(NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the... More

Clarivate Announces $250 Million Share Repurchase Program

August 3, 2021 6:45 AM UTC

LONDON, Aug. 3, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its Board of Directors has approved the purchase of up to $250 million of the Company's ordinary shares through open-market purchases, to be executed through October 31, 2021.

... More